Courtney Young on CRISPR Meets Duchenne: Scalable, Precise, Disruptive

Full Episode – Innovating Tomorrow’s Medicine ft. Dr. Courtney Young, CEO of MyoGene Bio.

In this exclusive preview, Dr. Courtney Young shares a glimpse into how MyoGene Bio is transforming the field of Duchenne Muscular Dystrophy using the gene editing technology CRISPR.

➡️ Full episode launches on 11 September

🔔 Subscribe and hit the bell so you don’t miss it!

🎙️ About the Show: Innovating Tomorrow’s Medicine features bold conversations with pioneers shaping the future of healthcare, biotechnology, and life sciences.

📌 Stay tuned for the full interview where we explore and share unique insights:

– The vision behind MyoGene Bio

– CRISPR and Duchenne Muscular Dystrophy

– Fund raising

– Leadership and culture

– Personal reflections and future outlook

#SneakPeek #Courtney Young #MyoGene Bio #Biotech #Cancer #FutureOfMedicine